add7 GmbH stands for competence and expertise in the fields of management consultancy, IT consulting and the development of innovative software products. Our specially developed eCRF „ecrom“ (a tool for the electronic relaization of clinical studies) enables our customers to carry out clinical studies and medical monitoring in a cost-efficient, uncomplicated and digital way. In doing so, our team responds individually to your needs and wishes regarding the design of the studies.

LISAvienna ist die gemeinsame Life Science Plattform von austria wirtschaftsservice und Wirtschaftsagentur Wien. Im Auftrag des Bundesministeriums für Digitalisierung und Wirtschaftsstandort und der Stadt Wien trägt sie zur Weiterentwicklung der Life Sciences in Wien bei. LISAvienna unterstützt innovative Biotechnologie-, Pharma- und Medizintechnik-Unternehmen in Wien, die neue Produkte, Dienstleistungen und Verfahren entwickeln und auf den Markt bringen. Die Plattform vernetzt diese Unternehmen mit Entwicklungspartnern und Leitkunden. Als zentraler Wissensträger liefert LISAvienna Entscheidungsgrundlagen für den Aufbau der Life Sciences in Wien und wirkt bei der Positionierung der Stadt Wien als eines der führenden europäischen Innovationszentren mit.

Unsere Services:

• Information & Beratung
• Vernetzung & Matching
• Expertise
• Marketing

The Austrian Neuroscience Association (ANA) aims at being the stage for the Neurosciences in Austria. We are the national partner for FENS (Federation of European Neuroscience Association) and by this connected to European Neuroscience and beyond. ANA organizes Annual Meetings and coordinates the annual international Brain Awareness Week that, under the patronage of the European Dana Alliance for the Brain (EDAB), takes place in several cities in Austria. ANA, on the other hand, has initiated a number of public discussions on science policy and research funding. We repeatedly reminded politicians – and will continue to do so in the future – that funding sciences is crucial for the prospects of our country.

Every other year, ANA awards the Otto Loewi price worth 5.300 € to outstanding neuroscientists who have accomplished a major part of their work in Austria. We provide travel grants for young scientists for ANA and FENS meetings, for the Brain Conferences in Copenhagen, for the FENS Summer (at Bertinoro/Italy) and Winter Schools (Kitzbühel/Austria), for the CAJAL Advanced Neuroscience Training Programme (at Champalimaud/Lisbon and Bordeaux/France), for slots in National Courses (of the NENS Schools program), and even for the transcontinental YITP exchange program with China, Japan, and Australia (see the FENS Website).

Axonlab  ist ein unabhängiges europäisches Distributions-, Dienstleistungs- und Produktionsunternehmen in den Bereichen medizinische Labordiagnostik, Life Science und Softwarelösungen.

Mit mehr als 27 Jahren Erfahrung im Markt steht Axonlab für hohe Exzellenz, ausgeprägte Servicequalität und innovative Systemlösungen. Das Unternehmen beschäftigt rund 300 Mitarbeiter in Österreich, der Schweiz, Deutschland, Belgien, Luxemburg, Tschechien, Slowenien, Kroatien und Holland. Axonlab versteht sich als nachhaltig agierendes Unternehmen, das für Krankenhäuser, Ärzte, Privatlaboratorien, Forschung und Industrie ein aktiver und zuverlässiger Partner ist.

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Axonlab is an independent corporation involved in distribution, service, software, and production activities for customers in medical/ diagnostic labs and the life sciences.

With its more than 27 years of experience, Axonlab stands for the highest degree of excellence in service and system oriented solutions. The company has more than 300 employees in Austria, Switzerland, Germany, Belgium, Czech Republic, Slovenia, Croatia and Netherlands. Axonlab sees itself as a sustainable company and an active and reliable partner for hospitals, doctors, private laboratories, and public and private research.

Die Firma Bartelt ist eine der führenden Labor-Komplettausstatter in Österreich und bietet umfangreiche Leistungen und Beratung in den Bereichen Laborausstattung, Laborbedarf, Chemikalien, Geräte-Service, Prozesstechnik und Laborsoftware.

Erklärtes Ziel der Firma Bartelt ist die flächendeckende Versorgung heimischer Labore und Forschungseinrichtungen, um den Forschungs- und Industriestandort Österreich im Rahmen der Möglichkeiten unterstützen zu können.

Berthold Technologies is a global detection and automation technology leader in life sciences. Our extensive range of product solutions made in Germany helps to ensure quality and performance for every lab.We provide user-friendly, accurate bioanalytical system solutions for biomedical, pharmaceutical, biotechnological, and basic research laboratories. These technologies make possible the identification, quantification and analysis of the molecular, physical and biological properties of thousands of substances and products. It is our mission to enable our customers to improve life in meaningful ways.

bio-ferm - Biotechnological Plant Protection

bio-ferm (Biotechnologische Entwicklung und Produktion GmbH) was founded in 2004 as a start-up spinn-off of the University of Natural Resources and Life Sciences Vienna (BOKU). bio-ferm is working on the international product registration and marketing of innovative biotechnological plant protection products.

Mode of action:
Microorganisms which were isolated from nature and fermented in the laboratory act as antagonists and prevent specifically the infection by pathogens (e.g. botrytis, storage diseases, fire blight).The advantages of our products are obvious: no chemical residues, no resistances, non-GMO production and registered for IP and organic growing systems.

www.bio-ferm.com

Open positions

BioCat GmbH, located in the Heidelberg Technology Park in close proximity to the German Cancer Research Center, is a privately held company founded in 2000 to market innovative products and services for life science research.

BioCat offers a wide range of high-quality research reagents as well as cutting-edge technologies in the fields of genomics, proteomics, and cell biology. For tissue-related applications, tissue microarrays as well as RNA, cDNA and proteins isolated from a wide variety of common and hard-to-obtain tissues are available. The product portfolio is grouped by applications and research areas making it easy to find the optimal solution for a research project.

The product offering comprises a large selection of antibodies, ELISA kits, cell-based assays, PCR, cloning and next generation sequencing reagents as well as tools for genome engineering (CRISPR/Cas9), gene silencing, microRNA analysis, exosome research, epigenetics and stem cell research.

The products and services provided have been developed by our partners in Canada, Germany and the US. They are made available through BioCat to researchers in academia as well as in pharma and biotech industry. 

With over a decade of experience in the European funding landscape, biolution has become Austria´s premier service provider for the application, management and communication of research projects in the life sciences.

biolution is a scientific communications and consulting company, by scientists for scientists. We support you professionally with our dedicated services:

• Grant application
• Project Management
• 3D Visualisation
• Event Organisation

Doxorubicin (red) is a classical chemotherapeutic which binds to DNA (blue) and inhibits Topoisomerase (yellow) 

BIOMIN - Naturally ahead!

Als Unternehmen in der Tierernährungsbranche entwickelt und produziert BIOMIN nachhaltige und qualitativ hochwertige Futtermittelzusätze und Vormischungen für eine gesunde und rentable Tierproduktion. Dazu zählen Lösungen für Mykotoxin-Risiko-Management, ein bahnbrechendes Konzept für natürliche Leistungsförderung, sowie andere spezifische Lösungen für Schweine, Geflügel, Wiederkäuer und Aquakultur.

Die firmeneigene Forschungsabteilung ist das Herz unseres Unternehmens, von dem alle Innovationen ausgehen. Unsere Wissenschaftler entwickeln neue Methoden, die den Grundstein für die Entwicklung neuartiger und wirksamer Futtermittelzusätze legen.

Unsere Kultur: Pioneers - Partners - Performers! 'Leaving foodprints' heißt für uns: Einen spürbaren Beitrag in der Futter(feed)- und Lebensmittel(food)-Industrie zu leisten.

BIOMIN ist Teil der ERBER Group.

Mehr Informationen unter www.biomin.net

Open positions

Meta-Consulting for Life Science organizations

Buchinger Life Science Solutions (BLiSS) is an integrated Life Science consultancy, founded in 2012 by Petra Buchinger.

Profile

BLiSS supports profit and non-profit Life Science organizations in finding successful solutions, mastering complex challenges, and reaching individual targets. BLiSS specializes in medical technology, pharmaceutical and biotech sciences, academic and non-academic research. An important BLiSS focus is sales, customer and service orientation, as well as intra- and inter-organizational cooperation and networking.

Expertise and Research Focus

BLiSS builds on 30 years of professional & consultancy expertise in Life Sciences and an extensive research study into the needs and chances of Life Science organizations. “DOES LIFE SCIENCE NEED CONSULTANCY?” is an empirical study that investigates requirements and potentials of consultancy in Life Science organizations. The study clearly illustrates typical challenges and problems in Life Science organizations and features ways how consultancy can help overcome them successfully.

Consulting Approach

BLiSS drives an integrated, scientifically sound counseling approach, firmly rooted in ethical behavior, to fully address the complexity of Life Science organizations and deliver sustainable results. We look at the organization as a whole with its internal and external network, individual features and relationships. Meta-consulting is used to integrate all organizational levels: Business structures, financial results, market focus, roadmap, work conditions, work-related issues, personality development, business & personal relationships. As a partner, BLiSS actively accompanies the complete process.

Consultation Process

BLiSS delivers highly individualized consultancy solutions, complete with practical hands-on support. The process starts with an extensive analysis of the current situation, integrating all stakeholders, and ends with the implementation of suitable measures and control of the results. BLiSS is at the customer’s side even after the end of the project, helping them move forward towards long-term success and sustainability of organization and portfolio.

Are you ready for BLiSS?

I look forward to meeting you!

Best regards,

Petra Buchinger

The mission of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences (www.cemm.at) is to achieve maximum scientific innovation in molecular medicine to improve healthcare.

At CeMM, an international and creative team of scientists and medical doctors pursues free-minded basic life science research in a large and vibrant hospital environment of outstanding medical tradition and practice.

CeMM’s research is based on post-genomic technologies and focuses on societally important diseases, such as immune disorders and infections, cancer and metabolic disorders.

CeMM operates in a unique mode of super-cooperation, connecting biology with medicine, experiments with computation, discovery with translation, and science with society and the arts.

CeMM trains a modern blend of biomedical scientists to make great contributions.

The goal of CeMM is to pioneer the science that nurtures the precise, personalized, predictive and preventive medicine of the future.

Zugänge öffnen
und Wissen bündeln

Vier Technopole vernetzen international anerkannte Spitzenforschungs- und Ausbildungseinrichtungen mit der Wirtschaft.
Die Schwerpunkte sind in Tulln natürliche Ressourcen und
biobasierte Technologien, in Krems Gesundheitstechnologien,
in Wr. Neustadt Medizin- und Materialtechnologien und in
Wieselburg Bioenergie, Agrar- und Lebensmitteltechnologie.

ecoplus. Die Wirtschaftsagentur
des Landes Niederösterreich.

enGenes Biotech develops customized solutions for the production of recombinant proteins in Escherichia coli and the baculovirus/insect cells expression systems by combining next-generation genetic engineering with a broad expertise in bioprocess engineering.

We offer the following services:

- Plasmid vector engineering / design

- Genetic engineering of expression hosts / baculovirus

- Bioprocess optimization

- Feasibility studies for difficult-to-express proteins

In addition to these services we are developing IP in the field of recombinant protein expression, soon available for out-licensing.

Eppendorf ist ein führendes Unternehmen der Life Sciences und entwickelt und vertreibt Instrumente, Verbrauchsartikel und Services für Liquid-, Sample- und Cell Handling zum Einsatz in Laboren weltweit. Das Produktangebot umfasst Pipetten und Pipettierautomaten, Dispenser, Zentrifugen und Mischer, Spektrometer, Geräte zur DNA-Vervielfältigung sowie Ultra-Tiefkühlgeräte, Fermentoren, Bioreaktoren, CO₂-Inkubatoren, Schüttler und Systeme zur Zellmanipulation. Verbrauchsartikel wie Pipettenspitzen, Gefäße, Mikrotiterplatten und Einweg-Bioreaktoren ergänzen das Sortiment an Premiumprodukten von höchster Qualität.

We rent out state-of-the-art scientific equipment and offer a lot of services in the areas of

• Chemistry
• Biochemistry,
• Genetics,
• Cell biology,
• Molecular biology,
• Biotechnology,
• Nanobiotechnology,
• Bioinformatics,
• Food sciences,
• Enzyme technology,
• Water and sewage.

Our direkt support of international renown researchers and scientists requires the highest standards of maintenance and operation of our equipment and services.

Standards that we can guarantee our customers.

ERBER Group
Pioneers - Parters - Performers

ERBER Group is a leading group of companies in the field of food and feed safety, with focus on natural feed additives, feed and food analysis and biotechnological plant protection with headquarters in Austria/Getzersdorf.

Our enterprise consists of BIOMIN, ROMER LABS, SANPHAR, and EFB including its affiliate companies bio-ferm and ERBER Enzymes. Including distribution partners, we are represented in more than 130 countries worldwide. Our international orientation and our in-house research and development are important success factors for our annual growth.

As an expert organization and world leader in the original core business of mycotoxin risk management we employ approximately 1400 employees. Powerful in-house research and development provides the basis for developing customer-focused and innovative solutions. This is particularly supported by collaborations with renowned universities and research institutions.

At ERBER Group we live the culture of Pioneers, Partners and Performers. For us, 'leaving foodprints' means making a significant contribution to the feed- and food industry.

More information at www.erber-group.net

www.erber-group.net

Open positions

EURAXESS Austria represents a national extension of the ›EURAXESS – Researchers in Motion‹ web portal, which is a unique pan-European initiative delivering information and support services to professional researchers. The initiative is a platform for researchers, entrepreneurs, universities and businesses to interact with each other. Backed by the European Union and its Member States, it supports researcher mobility and creates a more favourable environment for career development opportunities while enhancing scientific collaboration between Europe and the world. The EURAXESS initiative is a key element for implementing the European Research Area and an open labour market for researchers.

All services of the EURAXESS Network are free of charge.

If you wish to search for job opportunities or information about living in another European country, please visit the national EURAXESS portals in 40 European partner countries and contact their EURAXESS Centres.

The platform EURAXESS Meeting Point VIENNA offers different tools to support exchange and collaboration of researchers in the Vienna area in order to facilitate social integration of internationals.

A World Leader In Genomic Services.

Eurofins Genomics is part of the Eurofins Scientific Group, a life science company with 15,000 employees in more than 190 laboratories across 37 countries. We are excited about the power of DNA and how it is incorporated in everything we do. We are focussed on providing excellent customer support, together with the highest quality services, to ensure we remain as one of the world’s leading genomic service providers.
Eurofins Genomics is known globally for its innovative technologies in the life science arena including academic institutions, biotech and the pharmaceutical industry.
We have established an outstanding team of more than 500 talented experts and a broad range of technologies in the field of genomic services, forensics, agroscience, pharmaceutical, environmental, food and feed testing at our fully automated production facilities in Europe, USA, Japan and India. This unique team supports our approach to offer best practises and flexibility for all our clients – from academic institutions to large companies around the world.

Eurofins Genomics Markets.

Pharma & Diagnostics
We have extensive experience in applying the different genetic analysis methods and techniques which are crucial for the entire drug development and production process:

• Preclinical phase through all phases of clinical trials (phases I, II and III)
• Quality control for production of biologicals

Comprehensive services are available for all your study or project needs in the field of analysis, research and development. These services are available from single sample analysis all the way through to the high throughput levels involving several thousand samples.

Agriculture & Food
Important traits in agricultural plants and livestock such as yield, drought resistance, pathogen resistance, feed efficiency and quality linked parameters are genetically encoded.

Our agrigenomics services support:

• Plant breeding
• Farm animal & pet breeding
• Food production & authenticity testing

We provide a flexible, competent service with global reach, high industry standards and scalable capacity. One of our in-house experts will be assigned to be your project manager ensuring excellent support and communication. We will find the perfect solution for you by integrating the latest technologies for sequencing and genotyping.

Industrial Biotechnology
We can offer you individual genomics solutions from our industry leading service portfolio including:

• DNA & RNA extraction services
• Basic genomic, metagenomic & genetic characterisation
• Characterisation of genetic variability
• Residual host cell and pathogen DNA & RNA analysis
• Design and production of synthetic genes or gene evolution libraries
• GMO & genetic insert characterisation
• Assay design & validation

Research
From frequently used services such as DNA & RNA oligos and synthetic genes right through to genotyping, next generation sequencing and transcriptomics, we can offer you a broad portfolio of solutions and services for your research:

• DNA & RNA Oligonucleotides
• Custom DNA Sequencing
• Next Generation Sequencing
• Gene Synthesis & Molecular Biology
• Genotyping & Gene Expression Services

We have a great deal of expertise and experience in handling all types of research projects. Our expert team employs more than 80 PhD’s in all disciplines related to genomics to make your project a success.

Innovation And Expertise For Optimum Service.

DNA & RNA Oligonucleotides
Eurofins Genomics‘ expertise in the synthesis of oligo-nucleotides has made the company a European market leader and a strong global player with fully automated production facilities around the world. We apply proprietary processes to offer Optimised Application Oligos and synthetic nucleic acids in the highest quality and standards.

Custom DNA Sequencing
Eurofins Genomics has an international reputation as an expert for sequencing projects of all sizes, with the fastest turnaround times, and can also manage the most complex sequencing projects. Our sequencing service is accompanied by smart logistic concepts and accessories for your optimal service experience.

Next Generation Sequencing
As one of the first service providers for next generation sequencing, Eurofins Genomics continues to shape the future of NGS projects today with excellent know-how and proprietary protocols to cover a broad range of applications. Our unique skills in sample preparation, library generation and data analysis support your individual needs and allow you to utilise state-of-the-art technology.

Gene Synthesis & Molecular Biology Services
We provides gene synthesis services for standard genes, complex genes or gene libraries in a highly sophisticated and streamlined process by utilising our in-house oligonucleotide production and sequencing services. These are also used to ensure the highest quality control. With the help of our proprietary software GENEius*, Eurofins Genomics is fully geared to convert any DNA or amino acid sequence into its optimised synthetic gene which is perfectly designed for all types of applications.

Gene Expression & Genotyping
Our long-term expertise in DNA genotyping and gene expression analyses as well as our certified high-quality laboratories have ensured we have become an international leader in the fields of Applied Genetics, DNA Forensics and Pharmacogenetics producing hundreds of thousands processed DNA samples a year. Due to our outstanding and broad portfolio for the different markets we are the support centre for DNA and RNA testing within the global Eurofins group.

Customer Benefits.

Eurofins Genomics operates worldwide through a network of more than 500 talented employees positioned to serve both the emerging and established markets. Our whole team works industriously to establish new standards in the world of DNA and RNA.

The benefits of choosing Eurofins Genomics as your number one service provider are as follows:

• One-stop shop offering a large, integrated portfolio including consultation
• Convenient online shop with intuitive, easy-to-use software
• Individual logistic services (e.g. Drop-Box infrastructure for sample collection, courier service)
• Fast turnaround times through optimised high-throughput processes
• Dedicated customer support team and consulting service
• High-level scientific expertise of sales and laboratory team members
• Dedicated study directors and project managers

Quality Exceeds Customers' Expectations.

Quality is our top priority to ensuring we deliver products and services with the highest standards. This is fully demonstrated in our QM/QA-system and our quality policy. Our QM/QA-system is certified according to ISO 9001, including the requirements of ISO 13485 (medical devices requirements) and accredited according to ISO 17025. We are also compliant to the principles of Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).
Our quality policy is anchored in our QM/QA-system, which states our commitment to customer satisfaction through high quality products and services together with relevant compliance and accreditation. The quality policy of Eurofins Genomics extends to all of our employees and company associates since they are key for the success of our business.

Our quality management/quality assurance-system is:
• based on standards ISO 9001, ISO 13485, ISO 17025, GLP and GCP
• regularly monitored through internal and external audits
• documented in our quality manual
• documented and includes quality objectives and performance indicators for the continuous improvement of our products and services

With ~7,000 students, FH Campus Wien is the largest university of applied sciences in Austria. Molecular biotechnology represents one of the most promising research and economic sectors of the 21st century. The Biotechnology Section as part of Department of Applied Life Sciences at FH Campus Wien, includes the bachelor's program in Molecular Biotechnology and the English-language master's program in Molecular Biotechnology.
Research and development are a significant and growing part of the activities of the Department of Applied Life Sciences at FH Campus Wien. Partnerships with renowned universities, research institutes and hospitals as well as project-related funding from FFG, FWF and MA23 prove the recognized research expertise of the Biotechnology Section. In the Competence Center for Molecular Biotechnology, two research groups work in the fields of "Signaling Pathways" and "Immunology."

 

Das Studium „Biotechnische Verfahren“ wird seit 2002 von der Fachhochschule Wiener Neustadt am Campus Tulln angeboten. Die
Fachhochschule kooperiert dabei mit der BOKU, dem IFA-Tulln und den zahlreichen Biotech-Firmen am Campus.
Mit dem Universitäts- und Forschungszentrum sind über 700 Forscher in den Technologiefeldern Bioanalytik,
Umwelttechnik, Pflanzenproduktion, Nachwachsende Rohstoffe und Pharmazie am Campus tätig. Die Studierenden profitieren von
der Vernetzung von Ausbildung, Forschung und wirtschaftlicher Umsetzung ebenso wie von der Vielfalt an Forschungsthemen und
den daraus resultierenden beruflichen Möglichkeiten.

In Zusammenarbeit mit Forschungsinstituten, Industrie und Wirtschaft entstehen laufend thematische Impulse. Dabei werden sowohl Forschungsdienstleistungen im direkten Kundenauftrag getätigt, als auch öffentlich oder privat geförderte Forschungsvorhaben umgesetzt.

Dabei liegt der F&E Schwerpunkt im Bereich der Analyse und Charakterisierung von Naturstoffen und biotechnologischen Prozessen mittels chromatographischer, spektroskopischer und molekularbiologischer Verfahren sowie im Optimieren von Fermentationsprozessen und -medien im Labormaßstab auf Basis einer systematischen Versuchsplanung und begleitender Analysen.

Greiner Bio-One International GmbH ist ein Global Player mit mehr als 1800 Mitarbeitern und 23 Niederlassungen. Produziert wird an Standorten in Österreich, Deutschland, Ungarn, USA, Brasilien und Thailand. Unternehmenssitz der Aktiengesellschaft, die sich zu 100% im Eigentum der Familie Greiner befindet, ist Kremsmünster, Oberösterreich. Die Greiner Bio-One International GmbH ist ein Unternehmen der Greiner Gruppe.

"Ich bin gemeinsam mit meinen Mitarbeiterinnen und Mitarbeitern sehr stolz darauf, dass überall auf der Welt Wissenschaftler und Ärzte bei der Krebsforschung, der Virusdiagnostik oder der Impfstoffproduktion auf Produkte der Greiner Bio-One vertrauen. Es ist unser erklärtes Ziel, mit unseren Innovationen stets die besten Lösungen zu liefern." - Heinz Schmid, CEO Greiner Bio-One Bioscience

Haplogen is a young biopharmaceutical company with the mission to improve human health by combating infectious disease.

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that reprograms the body’s immune system.

HOOKIPA’s proprietary arenavirus-based technologies, non-replicating (VaxWave®) and replicating (TheraT®), induce robust antigen-specific CD8+ T cells and pathogen-neutralizing antibodies. HOOKIPA’s “off-the-shelf” viral vectors target antigen presenting cells in vivo to activate the immune system. Both technologies enable repeat administration to augment and refresh immune responses. As a monotherapy, our replicating arenavirus technology has the potential to induce CD8+ T cell response levels previously not achieved by other immuno-therapy approaches.

HOOKIPA’s non-replicating prophylactic Cytomegalovirus (CMV) vaccine candidate is currently in a Phase 2 clinical trial for patients awaiting kidney transplantation. To expand its infectious disease portfolio, HOOKIPA entered into a collaboration and licensing agreement with Gilead Sciences, Inc. to research arenavirus-based functional cures for HIV and chronic Hepatitis B infections.

In addition, HOOKIPA is building a proprietary immuno-oncology pipeline by targeting virally mediated cancer antigens, self-antigens and next-generation antigens. The lead replicating arenavirus oncology product candidates, HB-201 and HB-202, are in development for the treatment of Human Papilloma Virus 16-positive cancers. The Phase 1/2 clinical trial for HB-201 was initiated in December 2019. The HB-202 IND application was cleared by the FDA in June 2020.

Die Human.technology Styria GmbH ist eine wirtschaftspolitische Initiative zur Stärkung der Wettbewerbsfähigkeit der steirischen Unternehmen, Institutionen und wissenschaftlichen Einrichtungen im Bereich Humantechnologie. Die Zusammenarbeit von Wirtschaft, Forschung und Forschungsförderung ist ein Garant für den zukünftigen Erfolg von Unternehmen. Die Steiermark kann dabei auf zahlreiche kleine, mittlere und große Unternehmen im Umfeld Humantechnologie verweisen. Durch Co-Organisation, Kooperation und Koordination unterstützt der Cluster seine Mitglieder.

Human.technology.styria is a politico-economic initiative which sets out to boost the competitiveness of Styrian companies, institutions and scientific bodies working in the field of human technology. The cooperation in economics, research and research promotion will provide a guarantor for the future success of businesses. Styria can boast numerous small, medium and large enterprises in the field of healthcare technology. The cluster supports its members with coorganisation, cooperation and coordination of activities.

The Institute of Science and Technology Austria (IST Austria) is a young international institute dedicated to basic research and graduate education in the natural and mathematical sciences, located in Klosterneuburg on the outskirts of Vienna.

IST Austria is committed to conducting world-class research. By 2026, up to 90 research groups will perform research in an international state-of-the-art environment.

Learn more about us: ist.ac.at

LabBuddy supports lab teaching in transfering traditional lab education into a blendend learning approach. Creating better prepared students where students have a better understanding of theory and pratical work. Students are encouraged to think for themselves and create their own experiment design (starting with 1st year bachelor students and on). Finally time for in-depth discussion between students and teacher.

LabBuddy transforms the teachers curriculum in a blended learning approach in close communication with the teacher, therefore LabBuddy is always tailor made. The LabBuddy team does all implementation work for the teacher transferring the lab manual into the LabBuddy software, to prevent even more work where the teacher is looking for less work.

More than 330 lab courses have been transfered already throughout universities in Europe. We have multiple references who can tell what LabBuddy did to their lab education. Just ask.

This email address is being protected from spambots. You need JavaScript enabled to view it.

LabConsulting - Wir beraten Sie und verkaufen Groß- als auch Einzelhandelsprodukte von über 600 Herstellern - und das seit 1997. 

LabShop am Vienna BioCenter - Direktverkauf. Sie sparen Zeit, Geld und Arbeitskraft ! Laborprodukte, Beratung und technischer Support stets direkt vor Ort - Vienna BioCenter, Erne Seder Gasse 4/2, 1030 Wien

LabShop online - Onlineverkauf. www.labshop-online.com ;180.000 Produkte von mehr als 70 renommierten Herstellern - einfach digital

LabService - Direktsupport. Umfassendes Geräteservice und Pipetten-Kalibrierung

LabQ - Wir richten uns nach Ihren Bedürfnissen und entwickeln eigene innovative und ökonomische Produkte.

Gegründet im Jahr 2007 entwickeln wir in unseren Forschungslabors am Standort Campus Vienna Biocenter Produkte für die Molekularbiologie. Unser Portfolio umfasst eine vielfältige Produktpalette, Services sowie Software für die Datenanalyse im Anwendungsbereich RNA-Analyse und Next Generation Sequencing. Wir produzieren und vertreiben unsere Produkte auch selbst vom Standort Wien aus in einen weltweit rasant wachsenden Markt.

Produktion:

LI-COR® Biosciences Inc. ist führender Hersteller von Geräten für die Bio- und Umwelttechnologie sowie Pionier in der Entwicklung der Nahinfrarot-Fluoreszenztechnologie. Basierend auf dieser Technologie entwickelt LI-COR® Biosciences Detektionssysteme für Genomics, Proteomics und Molecular Imaging.

Forschungsschwerpunkte:

Protein Nachweissysteme (Western Blot Imaging), Fluoreszenzmarkierte Antikörper, Tumor Biomarker, Assays und Reagenzien für Proteomics Analysen und Wirkstoffentwicklung.

Dienstleistungen:

Direkter Vertrieb von Produkten über Online Shop (licor.con/bio/store) oder auf Anfrage.

Trainingskurse in den Bereichen Genomics und Proteomics, sowie Fluoreszenzauftragsmessungen zum Nachweis von Proteinen auf Membranen, Glass-Substraten und Mikrotiterplatten

LifeTaq is focusing on efficient automated as well as manual 3D cell cultivation and analysis with a focus on barrier models and toxicology applications. Our major advantages are increased standardization and reproducibility while reducing cost and time of our client's research in general. Since the current health crisis is challenging us every day, we are also implementing a fully digital solution for our clients in home-office via a cloud-based application for planning, monitoring and analysis of cells during the automated cultivation process.

Der Medizintechnik-Cluster der oö. Wirtschaftsagentur Business Upper Austria ist die zentrale Schnittstelle zwischen Wirtschaft, Wissenschaft und Medizin. Ziel ist es, die rund 230 Partner im Bereich der Medizintechnik zusammenzuführen und gemeinsame Projekte zu initiieren. Seit Bestehen des Clusters (2002) konnten bereits 84 Ideen der MedTech-Branche in Projekten erfolgreich umgesetzt werden.

Ausgehend vom zentralen Thema der Medizintechnik fokussiert der Cluster seine Aktivitäten auf 3 Schwerpunkte: MedTech.Transfer (mit der Initiative MedTech.Transfer), MedTech.IT (mit der Initiative Digital MedTech) und MedTech.Ein- & Umstieg (im Wesentlichen: Regulatorien). Mit der Initiative MedTech.Transfer hat sich der MTC zum Ziel gesetzt die Wirtschaft und Wissenschaft in Oberösterreich zu vernetzen, Unternehmen und Forschungseinrichtungen zusammenzuführen und bei der Initiierung und Umsetzung gemeinsamer Projekte im breiten Themengebiert der Medizintechnik zu unterstützen. Im Rahmen der Initiative MedTech.Transfer werden verschiedene Schwerpunktthemen wie (Molekular-)Diagnostik, Bildgebung, Elektronik/Sensorik, Nanomedizin, Werkstoffe und 3D-Druck behandelt.
 

Nähere Beschreibung: HIER

Metrohm Inula GmbH in Wien ist ein Tochterunternehmen der Metrohm AG in der Schweiz, einem der weltweit bedeutendsten Entwickler und Hersteller von Instrumenten und Software für die Titration und Voltammetrie, sowie für die Ionenchromatographie, Online-Analyse und Laborautomatisierung. Instrumente für die Nahinfrarot- und Raman-Spektroskopie runden das Metrohm-Produktportfolio ab.

Neben der Geräteherstellung werden Applikationen in den Labors entwickelt, welche Kunden helfen die Qualität ihrer Produkte zu sichern, Vorschiften zu erfüllen und Prozesse zu optimieren. Metrohm bietet Kunden aus allen Branchen, Hochschulen und der öffentlichen Hand Komplettlösungen an.

Metrohm Inula GmbH ist zudem der Ansprechpartner für Instrumente von Brookfield, Fritsch, Hitachi, Huber und IKA in Österreich.

Weiters besitzt das Unternehmen 5 eigene Niederlassungen in Mittel- und Osteuropa und ist das Regional Support Center für "Central and Eastern Europe."​ Unser Support reicht von der Ukraine über Südosteuropa bis nach Kasachstan.

The name says it all: Open Science - Life Sciences in Dialogue is all about making life sciences available to everyone. The association works in a wide variety of communication projects – from discussions to laboratory workshops, teacher training and citizen science projects – to stimulate discussion about life science topics and bring scientists together with school pupils, teachers and anyone else interested in learning more. The non-profit scientific association works closely with experts to make life sciences visible, tangible and understandable. Open Science draws on many years of experience and expertise in science communication when working on projects with a variety of target groups. The association operates independently and is committed to scientific integrity. Open Science does not represent any particular opinion on the applications of molecular biotechnology.

Lacerta Technologies is a regenerative medicine company harnessing the power of blood serum for human diseases. We combine our outstanding know-how in cell therapies with the expertise in growth factor research for the development of innovative orthobiologics. Our R&D is currently focused on inflammatory diseases, e.g. osteoarthritis, wound healing, as well as dental and orthopedic indications. The company is leveraging hereby the limited development risks and cost-competitive products with the effectiveness of regenerative therapies.

Lacerta Technologies has developed a diverse portfolio of proprietary orthobiologic products to enhance the body\'s innate ability for repair and regeneration:

1. Autologous Serum from Platelet Rich Fibrin. A point-of-care medical device for isolating a proprietary growth factor mix from the patient\'s blood has been developed. Ready to be re-applied within a short timeframe for inflammatory diseases (e.g. osteoarthritis), wound healing, ACL reconstruction, tennis elbow and sports surgery indications.

2. Serum albumin coated bone allografts. An off-the-shelf bone substitute which has most of the benefits of stem cells and growth factors without their cost and complexity. It induces the patient\'s own stem cells to proliferate resulting in fast remodeling of the graft.

3. A custom-made bone graft system for specialized clinics and tissue banks (GraftBuilder). It is capable of creating personalized bone graft coatings for demanding cases where inducing bone formation and fighting bacterial infection are both necessary.Lacerta Technologies is a regenerative medicine company harnessing the power of blood serum for human diseases. We combine our outstanding know-how in cell therapies with the expertise in growth factor research for the development of innovative orthobiologics. Our R&D is currently focused on inflammatory diseases, e.g. osteoarthritis, wound healing, as well as dental and orthopedic indications. The company is leveraging hereby the limited development risks and cost-competitive products with the effectiveness of regenerative therapies.

The Austrian Platform for Personalized Medicine (ÖPPM) represents a national networking platform that strives to connect all relevant parties in the field. Funded by the Austrian Federal Ministry of Education, Science and Research, and to ensure continuity, the ÖPPM was founded as a non-profit association by the three Medical Universities of Vienna, Graz and Innsbruck and the Austrian Academy of Sciences.

The overarching aim of our independent Platform is to promote the trans-sectoral linkage of all interested parties and disciplines engaged in application, research, implementation or communication of PerMed. These networking efforts foster new ways of strategic collaborations within the scientific community and leverage public outreach initiatives to inform the Austrian public. A continuous, wide debate on the benefits and challenges of current developments aims to contribute to a raising awareness and health literacy within our society.

Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, plasma-derived proteins, vaccines and classic pharmaceuticals.  Pall’s leading edge filtration, single-use systems, separation, purification and analytical technologies, as well as technical services in validation, assays and process optimization applicable to laboratory and pilot-scale development, play an essential role in the industry’s ability to manufacture these products.  As an established global provider of analytical and purification technologies, Pall supports faster development of new drugs and vaccines around the world, helping to make them safer and require less energy and water to produce.

Phoenestra is a startup active in the area of stem cells (iPSCs, MSCs) and products derived from these stem cells. We aim to provide an end-to-end approach to our oartners from fully compliant sourcing of donor materials to released GMP products which attach to the value chains of our partners and customers. As a spin-off from Evercyte GmbH, Phoenestra has access to exclusive IP regarding the use of urine-derived cells for reprogramming and IPS cell line generation. In addition, we have access to stable MSC lines and engineered extracellular vesicles.

PL BioScience offers human platelet-derived cell culture media called 'Human Platelet Lysate' (HPL). The German Biotech company was founded in 2015 as an RTWH Aachen University spin-off. Since then, the Human Platelet Lysate portfolio has been involved in renowned cell culture projects from academic research to stem cell therapies. Due to the human origin and rich growth factor content, the products support cell expansion in various regenerative medicine applications while complying with highest safety regulations.

Learn more about PL BioScience's broad HPL platform named ELAREM™: https://www.pl-bioscience.com

• Die richtigen Geräte in hoher Qualität auf dem neuesten Stand der Technik!
• Die Unterstützung von unseren Technikern! Sie übernehmen die Instandhaltung, Einschulung und Aufstellung aller Geräte.

ROMER Labs - Making the world's food safer!

Romer Labs zählt zu den weltweit führenden Anbietern diagnostischer Lösungen für die Lebens- und Futtermittelindustrie. Wir bieten ein umfangreiches Sortiment an innovativen Produkten und Dienstleistungen zum Nachweis von Mykotoxinen, Lebensmittelpathogenen, Lebensmittelallergenen, Gluten, GVO, Tierarzneimittelrückständen und anderen Lebensmittelkontaminanten.

Romer Labs betreibt 4 akkreditierte Service-Labors in Österreich, Großbritannien, den USA und Singapur. Unter Verwendung neuester Technologien in den Bereichen Chromatographie und Immunanalyse bieten unsere Labors Dienstleistungen für die Analyse von Mykotoxinen, Lebensmittelallergenen, Tierartenbestimmung in Fleisch, VDR und GVO.

Unsere Kultur: Pioneers - Partners - Performers! 'Leaving foodprints' heißt für uns: Einen spürbaren Beitrag in der Futter(feed)- und Lebensmittel(food)-Industrie zu leisten.

Romer Labs ist Teil der ERBER Group.

Mehr Informationen unter www.romerlabs.com

Open positions

Handel mit analytischen Laborgeräten - www.shimadzu.eu.com

SIRION Biotech offers customized viral vector engineering and production services for gene therapy and vaccination development. This possess an all-encompassing viral vector platform for adeno-, lenti- and adeno-associated viruses. De novo vector design enables the construction of individual cell models, catering to the needs of the customer’s work. The service platform enables and expedites advances in drug-, cosmetics- and food industries and independent research groups. To date SIRION has completed over 1500 projects of all sizes, working closely with over 200 customers from academia and industry. 

Das Unternehmen wurde 1963 gegründet und betrieb vor allem Handel mit Feinchemikalien.

Im Laufe der Jahre begann die Spezialisierung auf verschiedene Anwendungsgebiete wie z.B. molekularbiologische Fragestellungen, Zellkulturverbrauchsmaterialien, Laborgeräte und spezielle diagnostische Produkte.

Unsere 4 Geschäftsbereiche Diagnostik & molekulare Diagnostik , Laborgeräte & Service, Zellkultur & Verbrauchsmaterial sowie Forschungsprodukte & Biochemikalien halten ein Produktsortiment von mehr als 1.400.000 Artikeln und zahlreichen Dienstleistungen bereit.

Alle Produkte sowie zusätzliche Informationen wie z.B. Datenblätter können rasch und bequem in unserem Webshop abgerufen werden.

Takara Bio Europe is a member of the Takara Bio Group, a leading supplier of tools for life scientists worldwide.

Through our brand names TAKARA®, CLONTECH®, and CELLARTIS™, we develop innovative technologies in the fields of Cell Biology, Molecular Biology, and Stem Cells, including iPS derived hepatocytes and cardiomyocytes and a broad range of culture media, for stem cells or neural cells.

Takeda ist ein weltweit führendes, werteorientiertes forschendes biopharmazeutisches Unternehmen mit Hauptsitz in Japan. Das Unternehmen hat sich zum Ziel gesetzt, wissenschaftliche Erkenntnisse in hoch innovative Arzneimittel zu überführen und sich damit – getreu dem Unternehmensmotto „Better Health, Brighter Future“ – in den Dienst des Patienten zu stellen.

Die Betriebsstätten von Takeda in Österreich haben bereits eine lange Geschichte. Was 1778 begann ist heute der größte Pharmaarbeitgeber Österreichs und somit ein wichtiger Teil der heimischen pharmazeutischen Industrie. Takeda Österreich bedient die gesamte Wertschöpfungskette: beginnend mit der Aufbringung von humanem Blutplasma österreichweit in zehn eigenen Plasmazentren, über die Produktion von Arzneimitteln aus Humanplasma und anderen Medikamenten bis hin zum weltweiten Versand der fertigen Produkte. Die heimischen Forschungs- und Produktionsstätten befinden sich in Wien, Linz und Orth an der Donau. Rund 4.500 Mitarbeiterinnen und Mitarbeiter tragen täglich dazu bei, dass Medikamente aus Österreich in die ganze Welt gelangen und die Menschen in Österreich Zugang zu den innovativen Arzneimitteln von Takeda erhalten.

Das Produktportfolio hilft österreichischen Patienten unter anderem in den Bereichen Onkologie, Gastroenterologie, Immunologie, Hämophilie und Genetische Erkrankungen.

Who we are

THT Biomaterials is a privately-owned biotech start-up company based in the Vienna Biocenter Startup Labs (VBC6), Austria. Founded as a spin-off from the Ludwig Boltzmann Society in 2020, we specialized in the development and commercial production of non-cellular (= extracellular matrix) biomaterials of HUMAN PLACENTA. THT Biomaterials is run by an agile and highly motivated team of thriving engineers, industry experts, biologists, and academic researchers.

What we do

THT Biomaterials aims at changing the way cell culture is done today by providing HUMAN PLACENTA proteins from the extracellular matrix such as collagen or laminin for cell culture applications. Such fully human in vitro models result in better quality, less animal suffering (3R) and higher impact for researchers.

Our Vision

THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components.

THT Biomaterials isolates all its products from term placenta tissues that have been shown by certified tests to be negative for antibodies to HIV, HEP-B and THPA (syphilis) and informed consent of the mothers.

Why human placenta?

Animal material free cell culture (3R): The Three Rs (3Rs) in relation to science are guiding principles for more ethical use of animals in testing. The 3Rs are:

• Replace: substitute with alternative methods.
• Reduce: decrease the number of laboratory animals.
• Refine: minimise the pain and suffering of laboratory animals

 + Better quality because of the same species

• Humanizing in vitro models (3R)
• Less false positive/negative results
• More impact for researchers
• Faster into clinical applications

+ A potential source for an affordable personalized medicine

Placenta is an organ largely composed of foetal elements (personalized medicine) and probably the most easily accessible raw tissue material without causing additional harm to donors. Many human placenta-based products have already been successfully used in clinical approaches for over 100 years. We aim to use placenta biomaterials for:

• 2D coatings
• 3D gels/tissue ink
• in vitro spheroid and organiod studies
• in vitro toxicity studies
• Lab-On-Chip studies
• Organ-On-Chip studies
• personalized (autologous) filler over the long run.

Our products so far:

• HUMAN PLACENTA Collagen-I^A
• HUMAN PLACENTA Laminin-111^B
• HUMAN PLACENTA Substrate^C

A   Tissue Eng Part C Methods. 2017 May;23(5):274-285.Hackethal J et. al.

B   Novel Biomaterials for Regenerative Medicine 2018. Hackethal J et al.

C   Patent Nr. PCT/EP2019/05853

Vienna BioCenter is a leading life sciences location in Europe, offering an extraordinary combination of research, business and education on a single campus: 2000 employees, 1.500 students, 96 research groups and 35 biotech companies. Scientists from 79 nations create a highly dynamic environment of international standards. www.viennabiocenter.org

VOGELBUSCH plant und realisiert Anlagen für die biotechnologische Industrie. Mit Hauptsitz in Wien und Tochterfirmen in Katy, Texas und in Hong Kong bietet VOGELBUSCH weltweit Ingenieurdienstleistungen von der Projektstudie bis zur schlüsselfertigen Installation von Produktionsanlagen.

VOGELBUSCH ist ein Kompetenzzentrum für die biotechnologischen Schlüsselaufgaben Fermentation, Separation, Destillation und Evaporation und verfügt über ein breites Angebot von eigenen Technologien für die industrielle Produktion von Biocommodities wie Alkohol, Bioethanol, Essig, Hefe, Organischen Säuren und Stärkezucker.

Spezialisert auf zeit- & temperatukritische Sendungen weltweit.

Verpackungslösungen für folgende Temperaturen:

+15°C to +25°

+2° to +8°

-15° to -25°C

-80°C (Trockeneis)

-180°C (Stickstoff) 

Weltweit +150 eigene Offices. 24/7 Service global